Xiangling Zhu
Key Laboratory Of Anti Inflammatory And Immune Medicine
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IL-21 promotes the anti-tumor effect of anti-CD47 chimeric antigen receptor macrophages in ovarian cancer.
Journal: Communications biology
Published: February 04, 2025
Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development.
Journal: Annals of the rheumatic diseases
Published: May 09, 2024
Epigenetic Regulatory Axis MIR22-TET3-MTRNR2L2 Represses Fibroblast-Like Synoviocyte-Mediated Inflammation in Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 01, 2023
The application of HER2 and CD47 CAR-macrophage in ovarian cancer.
Journal: Journal of translational medicine
Published: June 12, 2023
Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
Journal: Life sciences
Published: December 07, 2022
Role of chemokine receptor 2 in rheumatoid arthritis: A research update.
Journal: International immunopharmacology
Published: October 10, 2022
Recent Updates on the Role of the MicroRNA-10 Family in Gynecological Malignancies.
Journal: Journal of oncology
Published: August 15, 2022
The role of a key transcription factor PU.1 in autoimmune diseases.
Journal: Frontiers in immunology
Published: July 23, 2022
PU.1 promotes development of rheumatoid arthritis via repressing FLT3 in macrophages and fibroblast-like synoviocytes.
Journal: Annals of the rheumatic diseases
Published: April 24, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026